Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 989 | 985 | 984 | 846 | 1319 | - |
Fund Return | -1.1% | -1.54% | -1.58% | -5.43% | 5.69% | - |
Place in category | 484 | 499 | 473 | 419 | 181 | - |
% in Category | 96 | 99 | 99 | 98 | 51 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1637619120 | 895.04M | 0.74 | -3.81 | - | ||
LU1637618742 | 378.1M | -3.68 | -7.75 | - | ||
AlphaBalanced B I | 141.38M | 5.50 | 2.14 | 3.31 | ||
AlphaBalanced B II | 141.38M | 5.52 | 2.22 | 3.39 | ||
AlphaBalanced B III | 141.38M | 5.54 | 2.33 | 3.51 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
DNCA Invest Europe Growth Class A s | 1.25B | 2.95 | 1.30 | 8.46 | ||
DNCA Invest Europe Growth Class B s | 1.25B | 2.81 | 0.92 | 8.07 | ||
DNCA Invest Europe Growth Class F s | 1.25B | 3.37 | 2.49 | 9.60 | ||
DNCA Invest Europe Growth Class I s | 1.25B | 3.30 | 2.30 | 9.46 | ||
LU1330191385 | 964.56M | 5.17 | 12.41 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 7.09 | 883.2 | +0.07% | |
ASML Holding | NL0010273215 | 6.83 | 864.50 | +1.96% | |
SAP | DE0007164600 | 6.83 | 176.060 | -0.97% | |
AstraZeneca | GB0009895292 | 5.29 | 12,370.0 | +0.31% | |
Richemont | CH0210483332 | 4.49 | 135.50 | +1.92% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Sell | Strong Buy |
Summary | Buy | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review